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Volume 60, Number 6 Abstracts 1725subsequently had postrevascularization APs or TPs greater than the CLI
criteria were removed from the cohort. Demographic factors, wound heal-
ing, amputation rates, and mortality were obtained and analyzed in relation
to the initial APs and TPs. Outcomes were measured using Kaplan-Meier
life-table analysis and Cox proportional hazards models.
Results: CLI criteria were identiﬁed in 443 limbs of 381 patients. Af-
ter revascularization, 98 limbs with AP or TP, or both, improved to
>70 mm Hg and 50 mm Hg were removed from the study cohort. In
45 limbs, patients did not respond to the intial revascularization and their
APs or TPs, or both, remained within CLI criteria. These limbs remained
in the patient cohort, yielding a ﬁnal group of 296 patients and 345 limbs.
Mean follow-up time was 2.0 years. In the entire patient cohort, limb loss
occurred in 24% at 1 year and in 31% at 3 years. Mortality was 32% at
1 year and 56% at 3 years. Amputation-free survival was 54% at 1 year
and 28% at 3 years. Lower TPs were associated with a signiﬁcantly higher
incidence of amputation. Among the 85 with an initial TP #10 mm Hg,
limb loss occurred in 46% at 1 year and in 60% at 3 years. This limb loss
was signiﬁcantly greater than limb loss of 18% at 3 years among the 115
with a TP of 31 to 50 mm Hg (P < .001, Fig). Amputation-free survival
in patients with a TP #10 mm Hg was 8% at 3 years.
Conclusions: CLI is associated with a high mortality, but not all pa-
tients with currently deﬁned hemodynamic criteria for CLI are at high risk
of limb loss. Patients with a TP between 31 and 50 mm Hg (41% of the
cohort) and not receiving revascularization or not responding hemodynam-
ically to revascularization experienced a low risk of limb loss. We recommend
revising the hemodynamic criteria for CLI to better identify patients at high
risk for limb loss who require intervention to improve outcomes.Fig. Limp salvage by toe hemodynamic pressure groups.
Fig. Primary patency: Percutaneous transluminal angioplasty (PTA) vs
stent.Author Disclosures: R. Vallabhaneni: None; C. A. Kalbaugh: None; A.
Kouri: None;M. A. Farber: None;W. A. Marston: Consultant, Celgene.
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Introduction: Signiﬁcant hepatic artery stenosis (HAS) after ortho-
topic liver transplantation (OLT) can lead to thrombosis with subsequent
liver failure in 30% of patients. Although operative intervention or retrans-
plantation has been the traditional solution, endovascular therapy has
emerged as a less invasive treatment strategy. Prior smaller studies have
been conﬂicting in the relative efﬁcacy of percutaneous transluminal angio-
plasty (PTA) vs primary stent placement for HAS.
Methods: This was a single-center retrospective review of all endovas-
cular interventions for HAS after OLT during a 54-month period (August
2009-December 2013). Patients with ultrasound evidence of severe HAS
(peak systolic velocity >400 cm/s, resistive index of <0.5, tardus parvus
spectral abnormalities) underwent endovascular treatment with primary
stent placement or PTA. Outcomes calculated were technical success, pri-
mary and primary assisted patency rates, reinterventions, and complications.
Results: Sixty-two interventions for HAS were performed in 42 pa-
tients with a mean follow-up of 19.1 6 15.2 months. During the study
period, the rate of treated HAS was 6.4% (42 of 654). Primary technical suc-
cess was achieved in 95% (59 of 62) of cases. Initial treatment was with PTA
alone (n ¼ 16) or primary stent (n ¼ 26). Primary patency rates after initialstent placement were 91%, 81.3%, 77%, and 77% at 1, 6, 12, and 24 months,
respectively, and signiﬁcantly better (P ¼ .01) compared with 68.8%, 57.1%,
44% for initial PTA (Fig). There were 20 reinterventions in 14 patients
(eight stents, six PTAs) for recurrent HAS. The time to initial reintervention
in patients with PTA alone vs initial stent was 51 and 105.8 days, respec-
tively. Stent placement was required in 75% of reinterventions, of which
ﬁve drug-eluting stents were placed. Overall Kaplan-Meier primary patency
rates were 82%, 70%, 63%, and 50% at 1, 6, 12, and 24 months, respectively.
Overall primary-assisted patency was 96% at 12 months and 93% at
24 months. Major complications were one arterial rupture treated endovasc-
ularly and two hepatic artery dissections. Long-term risk of HAT in the
entire patient cohort was 4.8%.
Conclusions: In this series, which represents the largest reported
cohort of endovascular interventions for HAS to date, we demonstrate
that HAS after OLT can be treated endovascularly with high initial technical
success and excellent primary assisted patency. Initial stent placement signif-
icantly decreased the need for reintervention. Avoidance of HAT is possible
in >95% of patients with endovascular treatment and close follow-up.Author Disclosures: L. Le: None;W. Terral: None;N. Zea: None;H. A.
Bazan: None; T. A. Smith: None; G. E. Loss: None; E. Bluth: None;W.
C. Sternbergh: None.
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Introduction: Groin wound infection is a costly and morbid event af-
ter lower extremity revascularization. To date, a comprehensive and vali-
dated method for identifying patients who are at greatest risk for this
complication, and who might therefore beneﬁt from prophylactic muscle
ﬂap coverage of their initial groin incision, has yet to be developed.
Methods: Our retrospective analysis included all patients at a single
institution who underwent lower extremity revascularization in which a
groin incision was used from 2009 through 2012. Patients were randomly
divided into two groups matched for operative year and surgeon: a pilot
group, which was used to develop a predictive model for our primary
outcome, and a validation group, which was used to test that model. The
primary outcome for our analysis was groin wound infection requiring oper-
ative intervention. Potential predictor variables included patient age, sex,
year of operation, previous groin incision, use of thrombolytic agents,
concomitant amputation, body mass index, smoking status, diabetes melli-
tus, end-stage renal disease, malnutrition, preoperative wound, type of
conduit, level of distal target vessel, and emergency status of the index oper-
ation. Best-ﬁt model selection methods were used to evaluate all possible
combinations, interactions, and transformation of potential predictor vari-
ables from the pilot patient group. The resulting model with the lowest
Akaike information criterion was selected for testing using the validation pa-
tient group. A user-friendly computer program was developed that uses this
model to predict an individual patient’s risk of operative groin wound
infection.
Results: The study included 284 patients, 141 in the pilot group and
144 in the validation group, who underwent lower extremity revasculariza-
tion procedures. Seventeen patients (12.1%) from the pilot group developed
groin incision infection that required operation. The predictive model that
